E2B (R3) and IDMP – Compliance with the New Reporting Regulations

Please join us for a complimentary webcast on February 23, 2017 when Michael Braun-Boghos, Oracle Health Sciences’ Director of Safety Analytics, will explain what life science companies need to do to comply with the new reporting regulations for E2B(R3) and IDMP.

The European Medicines Agency is in the process of implementing the new E2B(R3) and IDMP standards. E2B(R3) represents the most significant changes to safety reporting that the industry has seen in over a decade, and the way it is being implemented by the EMA requires companies to make major adjustments to their adverse event processing as well as their signal management procedures. IDMP defines hundreds of attributes per product and includes data that health authorities will make available to the public, so it means a new level of transparency for the industry. The Oracle Health Sciences Safety Suite with its Argus and Empirica solutions covers the end-to-end safety and pharmacovigilance needs of life science organizations.

Register now to secure your place. If you have any questions about this webcast, please contact Kate Andrews.

Please note that registration will close 1 hour before the scheduled start time.

We look forward to you joining us on the webcast!